Astellas Pharma Inc. ('Astellas') has launched an open innovation challenge 'Astellas Rx+ Healthcare Innovation Challenge' ('the Program'), with Agorize SAS (Head Office: Paris, France; Japan Country Manager: Ryota Nakazawa, 'Agorize')1, a company providing a global open innovation platform, aiming to create new Rx+ businesses2 beyond prescription drugs (Rx).
Through the Program, Astellas calls for new business ideas from start-up companies and students to accelerate the development of Rx+ businesses. The themes of the Program are related to the business areas ('Spheres3') 'Sensory function support/replacement' and 'Patient w/o effective medicines', defined in the strategic direction of Rx+ business creation ('Rx+ Story'). We look forward to receiving many innovative ideas from all over the world.
(C) 2020 Electronic News Publishing, source ENP Newswire